345 related articles for article (PubMed ID: 27815616)
21. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.
Györke T; Zajic T; Lange A; Schäfer O; Moser E; Makó E; Brink I
Nucl Med Commun; 2006 Jan; 27(1):17-24. PubMed ID: 16340719
[TBL] [Abstract][Full Text] [Related]
22.
Seth N; Seth I; Bulloch G; Siu AHY; Guo A; Chatterjee R; MacManus M; Donnan L
Pediatr Blood Cancer; 2022 Mar; 69(3):e29415. PubMed ID: 34709700
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.
Sharma P; Khangembam BC; Suman KC; Singh H; Rastogi S; Khan SA; Bakhshi S; Thulkar S; Bal C; Malhotra A; Kumar R
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1036-43. PubMed ID: 23558689
[TBL] [Abstract][Full Text] [Related]
25. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
Quinn B; Dauer Z; Pandit-Taskar N; Schoder H; Dauer LT
BMC Med Imaging; 2016 Jun; 16(1):41. PubMed ID: 27317478
[TBL] [Abstract][Full Text] [Related]
26. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations.
Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS
J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986
[TBL] [Abstract][Full Text] [Related]
27. Estimation of radiation dose to patients from (18) FDG whole body PET/CT investigations using dynamic PET scan protocol.
Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mondal A; Mishra AK; Dwarakanath BS
Indian J Med Res; 2015 Dec; 142(6):721-31. PubMed ID: 26831421
[TBL] [Abstract][Full Text] [Related]
28. Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors.
Gerth HU; Juergens KU; Dirksen U; Gerss J; Schober O; Franzius C
J Nucl Med; 2007 Dec; 48(12):1932-9. PubMed ID: 18006618
[TBL] [Abstract][Full Text] [Related]
29. 68Ga-PSMA-HBED-CC PET/CT and 18F-FDG PET/CT in Ewing Sarcoma.
Parihar AS; Sood A; Mittal BR; Kumar R; Singh H; Dhatt SS
Clin Nucl Med; 2020 Jan; 45(1):e57-e58. PubMed ID: 31524682
[TBL] [Abstract][Full Text] [Related]
30. 18F-FDG PET/CT of Primary Extraskeletal Ewing Sarcoma of the Prostate.
Guo YH; Yang MF
Clin Nucl Med; 2022 Dec; 47(12):e754-e755. PubMed ID: 36342806
[TBL] [Abstract][Full Text] [Related]
31. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic reference levels for
Alkhybari EM; McEntee MF; Brennan PC; Willowson KP; Kench PL
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):291-299. PubMed ID: 30770654
[TBL] [Abstract][Full Text] [Related]
33. Can FDG-PET assess the response to chemotherapy and predict tissue necrosis in osteosarcoma and Ewing sarcoma?
Andreani L; Ipponi E; Ruinato AD; Lupi T; Di Sacco F; Volterrani D; Coccoli L; Capanna R
Folia Med (Plovdiv); 2024 Apr; 66(2):196-202. PubMed ID: 38690814
[TBL] [Abstract][Full Text] [Related]
34. FDG PET/CT in a Case of Primary Pulmonary Ewing Sarcoma.
Zhang J; Dong A; Cui Y; Wang Y
Clin Nucl Med; 2019 Aug; 44(8):666-668. PubMed ID: 31274619
[TBL] [Abstract][Full Text] [Related]
35. Recurrent Metastatic Ewing Sarcoma Involving Only in the Muscles of Extremities Shown on FDG PET/CT.
Fleury AS; Zhuang H
Clin Nucl Med; 2024 Jun; 49(6):589-591. PubMed ID: 38537215
[TBL] [Abstract][Full Text] [Related]
36. Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies.
Quinn BM; Gao Y; Mahmood U; Pandit-Taskar N; Behr G; Zanzonico P; Dauer LT
BMC Med Imaging; 2020 Jan; 20(1):9. PubMed ID: 31996149
[TBL] [Abstract][Full Text] [Related]
37. Recurrent Subcutaneous Ewing Sarcoma on 18F-FDG PET/CT.
Wu J; Liu Y; Gong W; Liao T; Zhang C
Clin Nucl Med; 2021 Sep; 46(9):752-753. PubMed ID: 34374679
[TBL] [Abstract][Full Text] [Related]
38. Comparison of effective radiation doses from X-ray, CT, and PET/CT in pediatric patients with neuroblastoma using a dose monitoring program.
Kim YY; Shin HJ; Kim MJ; Lee MJ
Diagn Interv Radiol; 2016; 22(4):390-4. PubMed ID: 27306659
[TBL] [Abstract][Full Text] [Related]
39. Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
Marafi F; Esmail A; Rasheed R; Alkandari F; Usmani S
Nucl Med Commun; 2017 Sep; 38(9):764-770. PubMed ID: 28723715
[TBL] [Abstract][Full Text] [Related]
40. The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma.
Cistaro A; Lopci E; Gastaldo L; Fania P; Brach Del Prever A; Fagioli F
Pediatr Blood Cancer; 2012 Dec; 59(7):1206-10. PubMed ID: 22745027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
